
CRISPR therapy saves infant with rare metabolic disorder
CRISPR-based gene editing therapy has been used for the first time to treat CPS1 deficiency, which promises a new era for precision medicine.
CRISPR-based gene editing therapy has been used for the first time to treat CPS1 deficiency, which promises a new era for precision medicine.
Imperial researchers presented their work at this year’s conference in Liverpool
Felix's weekly digest of Science news
Felix's weekly digest of Science news
Professor John Tregoning’s latest book explores longevity through the lens of living well.
Promoting equity and transparency in scientific research and healthcare data storage.